Bausch Health Companies (BHC) Operating Expenses (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Operating Expenses came in at $2.1 billion in Q2 2026, up 1.25% year-over-year from $2.1 billion in Q2 2025, and down 39.21% quarter-over-quarter from $3.5 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Operating Expenses across 18 years of filings, most recently posting $2.1 billion for Q2 2026.
- In Q2 2026, Operating Expenses rose 1.25% year-over-year to $2.1 billion; the TTM figure through Jun 2026 stood at $10.0 billion (up 20.67% YoY), while the FY2025 annual figure was $8.5 billion, up 4.63% from the prior year.
- Operating Expenses came in at $2.1 billion for Q2 2026 at Bausch Health Companies, down from $3.5 billion in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.5 billion in Q1 2026 to a low of $1.6 billion in Q1 2022.
- Average Operating Expenses over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2023.
- Year-over-year, Operating Expenses slipped 27.36% in 2022 and surged 75.19% in 2026.
- Over 5 years, Operating Expenses stood at $2.4 billion in 2022, then slipped by 15.77% to $2.0 billion in 2023, then dropped by 2.2% to $2.0 billion in 2024, then advanced by 16.04% to $2.3 billion in 2025, then retreated by 9.04% to $2.1 billion in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $2.1 billion in Q2 2026, $3.5 billion in Q1 2026, and $2.3 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 1.29 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.45 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 356.56 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 195.34 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 2.11 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -65.41 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 225.58 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 53.74 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 16.14 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 3.47 Bn |
| Dec 31, 2025 | 2.32 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 2.19 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 2.43 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.63 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.54 Bn |